AGL
Agilon Health
$98.43
+$0.43 (+0.44%)Jul 27, 2026
Key metrics
The numbers that frame AGL today
- Market cap
- $1.64B
- P/E (TTM)
- -4.6
- EV / FCF
- -23.4
- Gross margin
- -2.5%
- EV / Sales
- 0.3
- ROIC
- -411.5%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $7.48
- 52wk High
- $133.04
Growth
Revenue and earnings trend for AGL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AGL
Is Agilon Health a good buy?
Yes. Agilon Health has excellent momentum, and it outweighs the weak quality here. Growth looks strong, which supports the long-term business case. We think Agilon Health is selling at a high price, which cuts against the buy case.
What is the market capitalization of AGL?
Agilon Health's market capitalization is $1.64B.
What is the P/E ratio for AGL stock?
Agilon Health's current P/E ratio is -4.6.
What is the 52-week high for AGL stock?
The 52-week high for Agilon Health is $133.04. The current close of $98.43 is 26% below that high.
What is the 52-week low for AGL stock?
The 52-week low for Agilon Health is $7.48. The current close of $98.43 is 1,215.9% above that low.
Does AGL stock pay dividends?
Agilon Health does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AGL?
Agilon Health's Debt / Equity ratio is 0.17.